Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$40.02−1.65 (-3.96%)
Close on Nov 17, 2026Market cap $1.87BP/E –Yield –
Septerna operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Septerna's operating cash flow for the twelve months ending Sep 30, 2026 was -$76.57M, down 173.5% year over year. For fiscal 2025 it was $110.19M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.19M | – |
| FY2024 | Dec 31, 2024 | -$67.47M | – |
| FY2023 | Dec 31, 2023 | -$38.72M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$13.77M | -108.2% |
| Q2 FY2026 | Jun 30, 2026 | -$22.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$25.63M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.99M | – |
| Q3 FY2025 | Sep 30, 2025 | $168.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$23.34M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.96M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.71M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.80M | – |
See a number that looks wrong?